Previous 10 | Next 10 |
AngioDynamics ( ANGO ) Q2 results : Revenues: $70M (unch). More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
Fiscal 2020 Second Quarter Highlights Net sales of $70.0 million, flat compared to the prior-year quarter Gross margin increased 140 basis points year over year to 59.3% GAAP loss per share of $0.07; adjusted earnings per share of $0.06 Announces the acquisition o...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of fiscal year 2020 before the market open on T...
Larry Culp is a Builder of Corporations, Not a Caretaker We've all heard the nostrum "The best defense is a good offense". The best way for General Electric (GE) to dig out of its liabilities is to change the growth profile and boost cash flow. The opportunity to gather revenue-generating ...
"There are memories that time does not erase... Forever does not make loss forgettable, only bearable. ”― Cassandra Clare Yesterday, we took a look at three small biotech stocks seeing huge new insider buying in recent days. Today, we will profile three stocks from outside...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer (CFO) will be departing the Co...
Image source: The Motley Fool. AngioDynamics (NASDAQ: ANGO) Q1 2020 Earnings Call Oct 03, 2019 , 8:00 a.m. ET Operator Continue reading
Thursday was a volatile day on Wall Street, but markets generally turned higher by the end of the session. Despite ongoing concerns about the future direction of the U.S. economy, there are still a number of factors pointing toward continued expansion and a low chance of a recession in the immed...
ANGO stock is down 16% today after MedDev company AngioDynamics Inc (NSADAQ:ANGO) agreed to acquire Eximo Medical for $46 million USD. The New York medical devices company has announced that it will acquire Israeli startup Eximo Medical Ltd, which develops a laser technology catheter de...
Gainers: PDS Biotechnology (NASDAQ: PDSB ) +23% . The Meet Group (NASDAQ: MEET ) +20% . Synthesis Energy Systems (NASDAQ: SES ) +14% . Microbot Medical (NASDAQ: MBOT ) +19% . TuanChe (NASDAQ: TC ) +14% . Arcturus Therapeutics Holdings (NASDAQ: ARCT ) +14% . Sorrento Therapeutics (NA...
News, Short Squeeze, Breakout and More Instantly...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that its management is schedule...
Equity Bancshares Inc. Class A (EQBK) is expected to report $0.92 for Q2 2024 Bank of America Corporation (BAC) is expected to report $0.79 for Q2 2024 Aehr Test Systems (AEHR) is expected to report $0.09 for Q4 2024 America Movil S.A.B. de C.V.n Depositary Shares (each representing t...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the fourt...